Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2019 3
2022 2
2023 5
2024 3
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for coene pl[au]
Your search for Coent PL[au] retrieved no results
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.
van der Wilk BJ, Eyck BM, Wijnhoven BPL, Lagarde SM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, van Klaveren D, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO Study Group. van der Wilk BJ, et al. Among authors: coene plo. Lancet Oncol. 2025 Apr;26(4):425-436. doi: 10.1016/S1470-2045(25)00027-0. Epub 2025 Mar 17. Lancet Oncol. 2025. PMID: 40112851 Clinical Trial.
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial.
Janssen QP, van Dam JL, van Bekkum ML, Bonsing BA, Bos H, Bosscha KP, Bouwense SAW, Brouwer-Hol L, Bruynzeel AME, Busch OR, Coene PLO, van Eijck CHJ, de Groot JWB, Haberkorn BCM, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, Liem MSL, Loosveld OJL, Luelmo SAC, Luyer MDP, Mekenkamp LJM, Mieog JSD, Nieuwenhuijs VB, Nuyttens JJME, Patijn GA, van Santvoort HC, Stommel MWJ, Versteijne E, de Vos-Geelen J, de Wilde RF, Zonderhuis BM, van der Holt B, Homs MYV, van Tienhoven G, Besselink MG, Wilmink JW, Groot Koerkamp B; Dutch Pancreatic Cancer Group. Janssen QP, et al. Among authors: coene plo. Lancet Oncol. 2025 Oct;26(10):1346-1356. doi: 10.1016/S1470-2045(25)00363-8. Epub 2025 Sep 10. Lancet Oncol. 2025. PMID: 40945523 Clinical Trial.
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.
Willems RAL, van Diepen AE, Dekker EN, Janssen QP, van Dam JL, Michiels N, van Eijck CWF, Hermans KEPE, Bonsing BA, Bosscha KP, Bouwense SAW, Busch OR, Ten Cate H, Coene PLO, van Eijck CHJ, van Es N, van der Harst E, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, de Laat B, Liem MSL, Mieog JSD, Nieuwenhuijs VB, Patijn GA, Roest M, van Santvoort HC, Valkenburg-van Iersel L, de Wilde RF, Wit F, Zonderhuis BM, Besselink MG, Homs MYV, van Tienhoven G, Wilmink JW, Groot Koerkamp B, de Vos-Geelen J; Dutch Pancreatic Cancer Group. Willems RAL, et al. Among authors: coene plo. J Clin Oncol. 2026 Mar 10;44(8):662-675. doi: 10.1200/JCO-25-01935. Epub 2026 Jan 29. J Clin Oncol. 2026. PMID: 41610374 Clinical Trial.
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial.
Dekker EN, Theijse RT, van Dam JL, Janssen QP, Stoop TF, Bonsing BA, Bosscha KP, Bouwense SAW, Busch OR, Coene PLO, van Eijck CHJ, van Her Harst E, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, Liem MSL, Mieog JSD, Nieuwenhuijs VB, Patijn GA, van Santvoort HC, Schreinemakers JMJ, de Wilde RF, Wit F, Zonderhuis BM, Homs MYV, van Tienhoven G, Wilmink JW, Besselink MG, Koerkamp BG; Dutch Pancreatic Cancer Group. Dekker EN, et al. Among authors: coene plo. Ann Surg. 2025 Aug 12. doi: 10.1097/SLA.0000000000006910. Online ahead of print. Ann Surg. 2025. PMID: 40792645
Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve.
Emmen AMLH, van den Broek BLJ, Hendriks TE, Busch OR, Bonsing BA, Cappelle ML, Coene PLO, Festen S, van der Harst E, de Hingh IHJT, van Laarhoven CJHM, Lips DJ, Sprakel J, Luyer MDP, Mieog JSD, van Santvoort HC, van der Schelling G, Wijsman JH, Patijn GA, de Wilde RF, Zwart MJW, Derksen WJM, Molenaar IQ, Groot Koerkamp B, Besselink MG; Members of the Dutch Institute for Clinical Auditing and the Dutch Pancreatic Cancer Group. Emmen AMLH, et al. Among authors: coene plo. Br J Surg. 2025 Nov 6;112(11):znaf210. doi: 10.1093/bjs/znaf210. Br J Surg. 2025. PMID: 41206577 Free PMC article.
Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer.
Gangaram Panday SSG, van Klaveren D, Lagarde SM, Lingsma HF, Mostert B, Coene PLO, Dekker JWT, Hartgrink HH, Heisterkamp J, Hutteman M, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JP, van Sandick JW, Sosef MN, van der Zaag ES, van Lanschot JJB, Wijnhoven BPL; SANO Study Group. Gangaram Panday SSG, et al. Among authors: coene plo. Ann Surg Oncol. 2026 Feb;33(2):946-954. doi: 10.1245/s10434-025-18531-y. Epub 2025 Oct 23. Ann Surg Oncol. 2026. PMID: 41128955 Free PMC article.
Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial).
Gangaram Panday SSG, van der Wilk BJ, Eyck BM, Lagarde SM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Husson O, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Steyerberg EW, Valkema R, van der Zaag ES, Lingsma HF, van Klaveren D, van Lanschot JJB, Wijnhoven BPL; Other Members of the SANO Study Group. Gangaram Panday SSG, et al. Among authors: coene plo. Br J Surg. 2025 Dec 24;113(1):znaf286. doi: 10.1093/bjs/znaf286. Br J Surg. 2025. PMID: 41591326 Clinical Trial.
Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study.
Achterberg FB, Mulder BGS, Janssen QP, Koerkamp BG, Hol L, Quispel R, Bonsing BA, Vahrmeijer AL, van Eijck CHJ, Roos D, Perk LE, van der Harst E, Coene PLO, Doukas M, Smedts FMM, Kliffen M, van Velthuysen MF, Terpstra V, Sarasqueta AF, Morreau H, Mieog JSD. Achterberg FB, et al. Among authors: coene plo. PLoS One. 2023 Jan 25;18(1):e0280939. doi: 10.1371/journal.pone.0280939. eCollection 2023. PLoS One. 2023. PMID: 36696439 Free PMC article.
Nationwide Association of Surgical Performance of Minimally Invasive Esophagectomy With Patient Outcomes.
Ketel MHM, Klarenbeek BR, Abma I, Belgers EHJ, Coene PLO, Dekker JWT, van Duijvendijk P, Emous M, Gisbertz SS, Haveman JW, Heisterkamp J, Nieuwenhuijzen GAP, Ruurda JP, van Sandick JW, van der Sluis PC, van Det MJ, van Esser S, Law S, de Steur WO, Sosef MN, Wijnhoven B, Hannink G, Rosman C, van Workum F; MIE-CAT Netherlands Collaborative Group. Ketel MHM, et al. Among authors: coene plo. JAMA Netw Open. 2024 Apr 1;7(4):e246556. doi: 10.1001/jamanetworkopen.2024.6556. JAMA Netw Open. 2024. PMID: 38639938 Free PMC article.
23 results